Status:
COMPLETED
Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations
Lead Sponsor:
Mayo Clinic
Conditions:
Vaccine Preventable Disease
Eligibility:
All Genders
18-101 years
Phase:
NA
Brief Summary
A cluster randomized trial will be conducted prior to widespread vaccine availability to the general public. Community-informed COVID-19 vaccine messages will be disseminated to participants. At basel...
Detailed Description
A cluster randomized trial with 80 participants from the social networks of 8 CLs will be conducted prior to widespread vaccine availability to the general public. Four CLs and social networks (cluste...
Eligibility Criteria
Inclusion
- Self-identification within a CLs social network
- Age 18 or greater
- Functional internet access.
Exclusion
- Does not self-identify within a CLs social network
- Is under the age of 18
- Does not have functional internet access.
Key Trial Info
Start Date :
February 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 3 2021
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT04765839
Start Date
February 12 2021
End Date
April 3 2021
Last Update
July 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905